News
Needham Reiterates Buy on Autolus Therapeutics, Maintains $9 Price Target
12 Apr 24
News, Price Target, Reiteration, Analyst Ratings
12 Health Care Stocks Moving In Thursday's After-Market Session
11 Apr 24
Movers
Truist Securities Maintains Buy on Autolus Therapeutics, Raises Price Target to $11
9 Apr 24
News, Price Target, Analyst Ratings
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
20 Mar 24
Movers
Breaking Down Autolus Therapeutics: 4 Analysts Share Their Views
18 Mar 24
Analyst Ratings
12 Health Care Stocks Moving In Friday's After-Market Session
15 Mar 24
Movers
Needham Maintains Buy on Autolus Therapeutics, Maintains $9 Price Target
14 Mar 24
News, Price Target, Analyst Ratings
Earnings Scheduled For March 14, 2024
14 Mar 24
Earnings
Autolus Therapeutics's Earnings Outlook
13 Mar 24
Earnings
Needham Maintains Buy on Autolus Therapeutics, Raises Price Target to $9
12 Feb 24
News, Price Target, Analyst Ratings
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
8 Feb 24
News
Press releases
Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (B-ALL)
2 Apr 24
Press Releases
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
14 Mar 24
Earnings, Press Releases
Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certification for Nucleus commercial manufacturing site
12 Mar 24
Press Releases, General
Autolus Announces Pricing of Underwritten Offering
8 Feb 24
Financing, Press Releases
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
8 Feb 24
Press Releases